Aptivus Adds Warning On Intracranial Hemorrhaging To Black Box
Labeling for Boehringer Ingelheim’s HIV drug was updated based on Phase III data of tipranavir coadministered with ritonavir (Abbott’s Norvir).
Labeling for Boehringer Ingelheim’s HIV drug was updated based on Phase III data of tipranavir coadministered with ritonavir (Abbott’s Norvir).